Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Image Removed

Image Added

Project Scope 

Create

This project aims to create a guidance about best data practices for patient foundations and for researchers in the form of decision trees, graphics, short printable materials or videos.


Project Statement 

The purpose of this Working Group is to create awareness and education about best practices for collecting regulatory quality data from the industry perspective, improving data quality, empowering patients and patient groups with knowledge and information, and building bridges between industry,

academic,

academics and patient communities.


Project Impact 

This project will create greater

partnership

partnerships between industry, researchers and the patient community. It will also help improve data collection, with the goal of the data being useful to the industry.




(Pfizer)zilber@pfizer ()Katie Warren ()
Project LeadsEmail

Sophia Zilber

, Alexion AstraZeneca Rare Disease, Cure Mito Foundation

sophia.

zilber@alexion.com

Danielle Boyce

, Johns Hopkins University

dboyce3@jhu.edu
Parag Shiralkar (Sumptuous Data Sciences)parag.shiralkar@sumptuous-ds.com
Paul Howard, Amicus Therapeutics

phoward@amicusrx.com

Nicola Newton, PHUSE Project Assistantkatie@phuse

nicky@phuse.global 


Status
colourBlue
titleCurrent Status

Q2/3 2022

Project approved Q3 2022.

Q1 2024

  • Drafted a lay language summary of recent FDA guidance



Objectives & Deliverables

Timelines

Decide on a strategy to share all three resources, possibly through PHUSE Education webinars Q2 2023


Published Deliverables
Ensuring Registry Data Relevance and Reliability for Regulatory Use4 April 2024
Myths VS Facts About Patient Registries18 May 2023

Patient Foundations Guide to Starting a Registry

28 April 2023

Patient Registry Transparency Checklist For Patient Foundations 

28 April 2023

Project Members

Organisation

Andrew MulbergNeurogeneDanielle BoyceJohns Hopkins UniversityParag ShiralkarSumptuous Data SciencesPaul HowardAmicus TherapeuticsSamantha RobicheauDatavantSophia ZilberPfizerTripti MulbergSyneoshealth